<?xml version="1.0" encoding="iso-8859-1"?>
<rss version="2.0"><channel><title>Individual feed for https://www.2minutemedicine.com/feed/</title><link>https://www.2minutemedicine.com/feed/</link><description>Individual feed output.</description><lastBuildDate>Wed, 27 Aug 2025 04:45:09 GMT</lastBuildDate><generator>PyRSS2Gen-1.1.0</generator><docs>http://blogs.law.harvard.edu/tech/rss</docs><item><title>Microneedling with tranexamic acid may improve outcomes for patients with melasma</title><link>https://www.2minutemedicine.com/microneedling-with-tranexamic-acid-may-improve-outcomes-for-patients-with-melasma/</link><image_url>https://www.2minutemedicine.com/wp-content/uploads/2017/12/doctor-patient-7-300x150.png</image_url><description>1. Among patients with melasma, microneedling with tranexamic acid was superior to microneedling with metformin or the control treatment in reducing m...</description><pubDate>Wed, 27 Aug 2025 00:00:06 GMT</pubDate></item><item><title>Long term safety and efficacy of rabies monoclonal antibody in post-exposure prophylaxis</title><link>https://www.2minutemedicine.com/long-term-safety-and-efficacy-of-rabies-monoclonal-antibody-in-post-exposure-prophylaxis/</link><image_url>https://www.2minutemedicine.com/wp-content/uploads/2015/01/injection_edited-e1441545841603-300x150.jpg</image_url><description>1. The rate of adverse events and seroresponse was similar between groups. 2. There were no incidents of rabies development in either group after 1-ye...</description><pubDate>Tue, 26 Aug 2025 22:55:25 GMT</pubDate></item><item><title>Tirzepatide leads to greater weight loss than semaglutide among adults with obesity</title><link>https://www.2minutemedicine.com/tirzepatide-leads-to-greater-weight-loss-than-semaglutide-among-adults-with-obesity/</link><image_url>https://www.2minutemedicine.com/wp-content/uploads/2014/08/scale_edited-300x150.jpg</image_url><description>1. In this randomized controlled trial, among adults with obesity, it was found that tirzepatide resulted in a significantly greater reduction in body...</description><pubDate>Tue, 26 Aug 2025 19:00:39 GMT</pubDate></item><item><title>Inavolisib lengthens progression-free survival time in HER2-negative advanced breast cancer</title><link>https://www.2minutemedicine.com/inavolisib-lengthens-progression-free-survival-time-in-her2-negative-advanced-breast-cancer-2/</link><image_url>https://www.2minutemedicine.com/wp-content/uploads/2013/04/Mammogram_showing_breast_cancer-300x150.jpg</image_url><description>1. In this randomized controlled trial, in patients with PIK3CA-mutated advanced breast cancer, the addition of inavolisib to a palbociclib-fulvestran...</description><pubDate>Tue, 26 Aug 2025 15:00:18 GMT</pubDate></item><item><title>Pembrolizumab improves survival in locally advanced head and neck cancer</title><link>https://www.2minutemedicine.com/pembrolizumab-improves-survival-in-locally-advanced-head-and-neck-cancer/</link><image_url>https://www.2minutemedicine.com/wp-content/uploads/2014/09/neck_edited-300x151.png</image_url><description>1. Among patients with locally advanced head and neck squamous-cell carcinoma (HNSCC), neoadjuvant and adjuvant pembrolizumab improved event-free surv...</description><pubDate>Tue, 26 Aug 2025 13:00:08 GMT</pubDate></item></channel></rss>